| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |